Literature DB >> 2471804

Identification of L2 open reading frame gene products of bovine papillomavirus type 1 using monoclonal antibodies.

X W Jin1, L M Cowsert, W P Pilacinski, A B Jenson.   

Abstract

Four hybridoma cell lines producing monoclonal antibodies (MAbs) to bovine papillomavirus type 1 (BPV-1) L2 open reading frame (ORF) gene products have been established from mice immunized with a BPV-1 L2-beta-galactosidase fusion protein. Hybridomas were selected and cloned (from over 700 hybridomas) on the basis of specific reactivity of supernatant fluids with BPV-1 L2 epitopes on disrupted BPV-1 particles and L2-beta-galactosidase fusion proteins by ELISA and Western blotting, and with acetone-fixed frozen sections of BPV-1-induced fibropapillomas by immunofluorescence. These MAbs were not reactive with intact BPV-1 particles or BPV-1 L1-beta-galactosidase fusion proteins by ELISA or with beta-galactosidase by ELISA and Western blotting. The four MAbs detected viral structural proteins of Mr 76K, 68K and possibly 55K in purified BPV-1 preparations by Western blotting. Two of the four MAbs were cross-reactive with BPV-2-induced fibropapillomas. These findings suggest that (i) the BPV-1 L2 ORF encodes the minor capsid protein(s), (ii) the gene products of the BPV-1 L2 ORF have Mr values of 76K, 68K and possibly 55K, (iii) minor capsid epitopes are internal to the BPV-1 particle, and (iv) MAbs reactive with genetically engineered truncated BPV-1 L2 ORF gene products can distinguish between BPV-1 and BPV-2 productive infections.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2471804     DOI: 10.1099/0022-1317-70-5-1133

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Preparation and properties of a papillomavirus infectious intermediate and its utility for neutralization studies.

Authors:  Joshua W Wang; Subhashini Jagu; Kihyuck Kwak; Chenguang Wang; Shiwen Peng; Reinhard Kirnbauer; Richard B S Roden
Journal:  Virology       Date:  2013-12-20       Impact factor: 3.616

2.  The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains.

Authors:  P M Day; R B Roden; D R Lowy; J T Schiller
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

3.  L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidation.

Authors:  M M Okun; P M Day; H L Greenstone; F P Booy; D R Lowy; J T Schiller; R B Roden
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

4.  Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.

Authors:  R Kirnbauer; F Booy; N Cheng; D R Lowy; J T Schiller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

5.  Differentiation-specific expression from the bovine papillomavirus type 1 P2443 and late promoters.

Authors:  S K Barksdale; C C Baker
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

Review 6.  L2, the minor capsid protein of papillomavirus.

Authors:  Joshua W Wang; Richard B S Roden
Journal:  Virology       Date:  2013-05-17       Impact factor: 3.616

7.  Differentiation-specific alternative splicing of bovine papillomavirus late mRNAs.

Authors:  S Barksdale; C C Baker
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

8.  Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins.

Authors:  R B Roden; E M Weissinger; D W Henderson; F Booy; R Kirnbauer; J F Mushinski; D R Lowy; J T Schiller
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

9.  Molecular Characterization of Human Papillomavirus Type 159 (HPV159).

Authors:  Iva Marković; Lea Hošnjak; Katja Seme; Mario Poljak
Journal:  Viruses       Date:  2021-08-23       Impact factor: 5.048

10.  Cleavage of the HPV16 Minor Capsid Protein L2 during Virion Morphogenesis Ablates the Requirement for Cellular Furin during De Novo Infection.

Authors:  Linda Cruz; Jennifer Biryukov; Michael J Conway; Craig Meyers
Journal:  Viruses       Date:  2015-11-11       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.